Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

A Multimodal Music Therapy Intervention for Engaging Persons With Severe Dementia

NCT06605157 · View on ClinicalTrials.gov ↗

Study Summary

The goal of this pilot randomized clinical trial is to learn if a music therapy treatment, called AMUSED, can improve engagement and reduce behavioral symptoms in older adults with severe dementia who live in care facilities. The main questions it aims to answer are: * Is it feasible to conduct a full-scale trial of AMUSED? * Can investigators identify the best outcome measures to assess impact on behavioral symptoms of dementia? * Does speech offer a useful indicator of treatment effectiveness? Researchers will compare a group-based music therapy treatment to a reading activity to learn if music therapy leads to greater improvements in behavioral symptoms and speech patterns. Participants will: * Participate in either music therapy (includes live music, singing, and rhythmic instrument playing) or a reading group with stories about life and nature and talk about memories. * Attend small group sessions twice a week for 12 weeks, with each session lasting 40 minutes between lunch and dinner. * Be observed and assessed for behavioral symptoms, cognition, and speech several times during treatment and at a 4-week follow-up.

Conditions Studied

Interventions

  • BEHAVIORAL AMUSED
  • BEHAVIORAL Reading Aloud

Study Locations (9)

Kentucky

  • Cedar Ridge Health Campus — Cynthiana
  • Walker's Trail Senior Living — Danville
  • University of Kentucky — Lexington
  • Magnolia Springs Senior Living — Lexington
  • Sayre Christian Village — Lexington
  • The Homeplace at Midway — Midway
  • Windsor Care Center — Mount Sterling
  • Daisy Hill Senior Living — Versailles
  • Thomson-Hood Veterans Center — Wilmore

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2025-03-12
Est. Completion 2026-06-30
Phase NA

Sponsor

Alaine E Hernandez, PhD

28 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06605157

The ClinicalTrials.gov registry entry for NCT06605157 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alaine E Hernandez, PhD, which has 28 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 1 condition, with Dementia Severe appearing as the primary indexed condition, and to 2 interventions — of which AMUSED is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06605157 reports 9 study locations spanning 1 distinct geographic area — top geographies include Kentucky. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06605157 about?

NCT06605157 is a clinical study titled "A Multimodal Music Therapy Intervention for Engaging Persons With Severe Dementia". The goal of this pilot randomized clinical trial is to learn if a music therapy treatment, called AMUSED, can improve engagement and reduce behavioral symptoms in older adults with severe dementia who live in care facilities. The main questions it aims to answer are: * Is it feasible to conduct a f...

What is the current status of trial NCT06605157?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2025-03-12. Estimated completion is 2026-06-30.

What conditions does trial NCT06605157 study?

This clinical trial studies the following conditions: Dementia Severe. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06605157?

The interventions under investigation include: AMUSED (BEHAVIORAL), Reading Aloud (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06605157?

This trial is sponsored by Alaine E Hernandez, PhD, which has 28 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06605157 being conducted?

This trial has 9 study locations across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial